Surgery News and Research

RSS

Gene research offers new hope for targeted breast cancer treatment

CANCER RESEARCH UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology* today (Monday).

2 Mar 2010

Celsion to commence Phase II Study of ThermoDox and RFA for CRLM

Celsion Corporation today announced that it will initiate a Randomized Phase II Study of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Radiofrequency Ablation (RFA) for Colorectal Liver Metastases (CRLM). Dr. Steven K. Libutti, Professor and Vice Chairman, Department of Surgery and Director of the Montefiore-Einstein Center for Cancer Care and Albert Einstein College of Medicine in New York City, will serve as Principal Investigator for the study.

2 Mar 2010

Study shows high rate of shoulder dislocation in young males and elderly women

An article published in the March 2010 issue of The Journal of Bone and Joint Surgery reveals that the majority of all shoulder dislocations occur during sports activities and young males are at a higher risk. The study also shows a high rate of shoulder dislocation in elderly women.

2 Mar 2010

MiMedx Group's HydroFix Spine Shield device receives CE Mark

MiMedx Group, Inc. announced today that the Company received the CE Mark for its HydroFix™ Spine Shield device and was certified for design, development, and production of post-surgical adhesion inhibiting barriers.

1 Mar 2010

ATS Medical: First human robot assisted endoscopic aortic valve replacement in the Midwest

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced the first human robot assisted endoscopic aortic valve replacement in the Midwest using the daVinci® Surgical System from Intuitive Surgical to implant the ATS 3f ® Aortic Bioprosthesis. The procedure was recently performed by Husam H. Balkhy, M.D., at the Wisconsin Heart Hospital in Milwaukee, Wisconsin.

1 Mar 2010

Bayer HealthCare Pharmaceuticals' RECOTHROM solution receives Health Canada approval

Bayer HealthCare Pharmaceuticals announced today that RECOTHROM(R) (Thrombin alfa (Recombinant)), the first recombinant, plasma-free thrombin approved by Health Canada, is now available for use as a topical hemostatic solution. According to a recent clinical study, RECOTHROM(R) was found to successfully stop 80 per cent of surgical bleeding within three minutes and 95 per cent of bleeding within 10 minutes.

1 Mar 2010

Two stroke-prevention procedures are equally beneficial for men and women, but effectiveness vary by age

Two stroke-prevention procedures are safe and equally beneficial for men and women at risk for stroke, but the effectiveness does vary by age, say researchers at the University of Alabama at Birmingham in collaboration with other North American stroke investigators.

1 Mar 2010

Caddisfly silk and sandcastle worm glue: Potential adhesives during surgery

Like silkworm moths, butterflies and spiders, caddisfly larvae spin silk, but they do so underwater instead on dry land. Now, University of Utah researchers have discovered why the fly's silk is sticky when wet and how that may make it valuable as an adhesive tape during surgery.

1 Mar 2010

Diagosis of head and neck lesions: Ultrasound-guided FNA better than standard palpation technique

Office-based, surgeon-performed, ultrasound-guided, fine needle aspiration (FNA) of head and neck lesions yields a statistically significant higher diagnostic rate compared to the standard palpation technique, indicates new research in the March 2010 issue of Otolaryngology - Head and Neck Surgery.

1 Mar 2010

NPS Pharmaceuticals supports second annual U.S. Rare Disease Day observance

NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today its support for the second annual U.S. Rare Disease Day observance on February 28.

1 Mar 2010

FiberNet EPS has 97.5% success rate in patients undergoing CAS: EPIC study

A multicenter EPIC (FiberNet- Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published early online in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.

1 Mar 2010

Screening crucial for Triple A and more awareness needed

On Feb. 22, the day after America watched some of its strongest hearts compete in Vancouver on the 30th anniversary of the “Miracle on Ice” hockey game, a lucky patient at El Camino Hospital was recuperating from his own miracle.

1 Mar 2010

BDSI provides update on product portfolio, key upcoming milestones

BioDelivery Sciences International, Inc. today provided a summary of its business overview webcast that was conducted on Thursday, February 25, 2010. Dr. Mark A. Sirgo, President and Chief Executive Officer, and Dr. Andrew L. Finn, Executive Vice President of Product Development, provided an update on the product portfolio, including development plans, anticipated timelines, and key upcoming milestones.

28 Feb 2010

Brain cancer awareness: 55-year-old cycles across USA

Anne Feeley, a 55-year-old mother and brain cancer survivor, will cycle across the country this spring to raise awareness and money for brain cancer research and support.

27 Feb 2010

NuVasive: Aetna changes spinal surgery policy to include coverage for XLIF procedure

NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Aetna changed its spinal surgery policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as experimental and investigational.

27 Feb 2010

University of Michigan Health System opens new facility for eye care, diabetes research

On March 1, the first eye patients will enter an innovative new $132 million facility that expands the University of Michigan Health System's capacity for eye care, research and education, and unites diabetes researchers as they work to accelerate the search for a cure and prevention of diabetes.

27 Feb 2010

Minimally-invasive procedure as effective as gold standard for treating carotid artery blockages: Study

A major study shows that a minimally-invasive procedure is as effective and safe as the gold standard for treating blockages of the carotid artery, giving patients who prefer a less invasive procedure a proven alternative.

27 Feb 2010

"Smart Hip": Non-evasive method to regenerate bone tissue

To monitor the real-time performance of bone implants is the challenge of "Smart Hip", an innovative medical device that aims to reduce the number of surgical interventions in the hip area and regenerate bone tissue by using non-evasive methods. The concept's validation - unique in the world and developed by a PHD from the Faculty of Engineering of the University of Porto -, has already been successfully tested on animals.

27 Feb 2010

Thomas Jefferson University Hospital CLP receives Outstanding Performance Award

Adam Berger, M.D., a Cancer Liaison Physician (CLP) at Thomas Jefferson University Hospital, recently received an Outstanding Performance Award for going above and beyond the scope of the normal duties of serving as a liaison between the hospital's cancer program and the American College of Surgeons Commission on Cancer (CoC).

27 Feb 2010

Overall incidence of stroke, heart attack and death similar in carotid endarterectomy and stenting procedures

The two major procedures for opening blocked neck arteries to restore blood flow to the brain proved similar in overall long-term safety and efficacy, but showed differences in stroke and heart attack in the weeks following the procedure, according to late-breaking science presented at the American Stroke Association's International Stroke Conference 2010.

27 Feb 2010

Surgery News and Research

Gene research offers new hope for targeted breast cancer treatment

Celsion to commence Phase II Study of ThermoDox and RFA for CRLM

Study shows high rate of shoulder dislocation in young males and elderly women

MiMedx Group's HydroFix Spine Shield device receives CE Mark

ATS Medical: First human robot assisted endoscopic aortic valve replacement in the Midwest

Bayer HealthCare Pharmaceuticals' RECOTHROM solution receives Health Canada approval

Two stroke-prevention procedures are equally beneficial for men and women, but effectiveness vary by age

Caddisfly silk and sandcastle worm glue: Potential adhesives during surgery

Diagosis of head and neck lesions: Ultrasound-guided FNA better than standard palpation technique

NPS Pharmaceuticals supports second annual U.S. Rare Disease Day observance

FiberNet EPS has 97.5% success rate in patients undergoing CAS: EPIC study

Screening crucial for Triple A and more awareness needed

BDSI provides update on product portfolio, key upcoming milestones

Brain cancer awareness: 55-year-old cycles across USA

NuVasive: Aetna changes spinal surgery policy to include coverage for XLIF procedure

University of Michigan Health System opens new facility for eye care, diabetes research

Minimally-invasive procedure as effective as gold standard for treating carotid artery blockages: Study

"Smart Hip": Non-evasive method to regenerate bone tissue

Thomas Jefferson University Hospital CLP receives Outstanding Performance Award

Overall incidence of stroke, heart attack and death similar in carotid endarterectomy and stenting procedures

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News